Research Article
Effect of Topical Brimonidine 0.15% on Conjunctival Injection after Strabismus Surgery in Children
Table 1
Baseline characteristics of patients receiving topical brimonidine 0.15% and the control group.
| Characteristics | Brimonidine (n = 32) | Control (n = 31) | Total (n = 63) | P value |
| Sex (M : F) | 18 : 14 | 18 : 13 | 36 : 27 | 0.884 | Laterality (R : L) | 15 : 17 | 17 : 14 | 32 : 31 | 0.527 | Mean age (years) | 9.2 ± 1.1 (7.7–11.8) | 9.0 ± 1.0 (7.6–11.6) | 9.1 ± 1.0 (7.6–11.8) | 0.549† | Cycloplegic refraction (D) | −1.30 ± 1.61 (−5.25–+2.25) | −1.34 ± 1.82 (−6.50–+1.25) | −1.32 ± 1.70 (−6.50–+2.25) | 0.916† | Angle of deviation (PD) | Distance | 23.2 ± 7.4 (12−45) | 22.8 ± 7.2 (12–45) | 23.0 ± 7.2 (12–45) | 0.824† | Near | 29.9 ± 8.3 (15−45) | 27.0 ± 8.6 (12–40) | 28.5 ± 8.5 (12–45) | 0.177† | Surgical dosage (mm) | Medial rectus muscle | 6.1 ± 0.9 (4.0–7.0) | 5.7 ± 1.2 (3.5–7.0) | 5.9 ± 1.0 (3.5–7.0) | 0.168† | Lateral rectus muscle | 5.6 ± 1.2 (4.0–8.5) | 5.4 ± 1.2 (3.5–8.5) | 5.5 ± 1.2 (3.5–8.5) | 0.605† |
|
|
M = male; F = female; R = right; L = left; D = diopters; PD = prism diopters. value by Pearson’s χ2 test. value by independent t-test. |